DOI: 10.25881/20728255_2023_18_1_20


Borzov E.A. 1, Silaev A.A.2, Vasyagin E.V.2, Kolomeichenko N.A.2, Sukhotin V.N.2, Zorin E.V.2

1 National Medical Research Center of Cardiology named after academician E.I. Chazova, Moscow

2 Clinical Hospital of the Administration of the President of the Russian Federation, Moscow


Rationale: Coronary artery bypass grafting (CABG) in patients with coronary heart disease (CHD) and atrial fibrillation (AF) can be performed in combination with surgical ablation of arrhythmogenic areas of the heart. Current clinical guidelines consider the possibility of simultaneous intervention with class IIa, which is a consequence of the lack of a sufficient evidence base.

Objective: to evaluate the effectiveness and safety of CABG and ablation in the modification «Labyrinth IV».

Materials and methods. A prospective randomized study was performed. The study group with simultaneous surgical treatment of coronary heart disease and AF included 111 patients (CABG+RFA group), the control group with isolated CABG included 110 patients (CABG group). Hospital and yearly outcomes were assessed. The end point was AF recurrence. The end point at the post-hospital stage (6 and 12 months after surgery) was assessed using 24-hour ECG monitoring. A comparative analysis of the results in both groups was performed.

Results: Initial clinical and demographic parameters in both groups did not differ, most patients were men over 60 years of age. The duration of surgical treatment in terms of myocardial ischemia time and duration of cardiopulmonary bypass was higher in the CABG+RFA group. At the hospital stage, in the CABG + RFA group, temporary pacing was required somewhat more often, while there were no significant differences in the need for implantation of a permanent pacemaker. “Freedom” from AF recurrence at the hospital and post-hospital stages was significantly higher in the CABG+RFA group, the most significant differences were obtained at the 12-month follow-up stage (96.3% vs. 57.3%, p<0.05). CABG+RFA is accompanied by a significant decrease in the size of the left atrium (LA), while the large size of the LA increases the risk of AF recurrence in the post-hospital period.

Conclusion: Simultaneous CABG and RFA compared with isolated CABG is characterized by a high degree of «freedom» from angina recurrence. The safety of surgical ablation is regarded as satisfactory.

Keywords: coronary artery bypass grafting, atrial fibrillation, radiofrequency ablation, simultaneous coronary artery bypass grafting and radiofrequency ablation.


1. Ivanov DO, Orel VI, Aleksandrovich YuS. Diseases of the cardiovascular system as the leading cause of death in russian federation: ways of problem solution. Meditsina i organizatsiya zdravookhraneniya. 2019; 2: 4-12. (In Russ.)

2. Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association [published correction appears in Circulation. 2020; 141(2): e33]. Circulation. 2019; 139(10): e56-e528. doi:10.1161/CIR.0000000000000659.

3. Turakhia MP, Shafrin J, Bognar K, et al. Estimated prevalence of undiagnosed atrial fibrillation in the United States. PLoS One. 2018; 13(4): e0195088. doi:10.1371/journal.pone.0195088.

4. Kralev S, Schneider K, Lang S, Süselbeck T, Borggrefe M. Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One. 2011; 6(9): e24964. doi:10.1371/journal.pone.0024964.

5. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet. 2009; 373(9658): 155-166. doi:10.1016/S0140-6736(09)60040-4.

6. Seiffge DJ, Werring DJ, Paciaroni M, et al. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol. 2019; 18(1): 117-126. doi:10.1016/S1474-4422(18)30356-9.

7. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42(5): 373-498. doi:10.1093/eurheartj/ehaa612.

8. Shin H, Hashizume K, Iino Y, Koizumi K, Matayoshi T, Yozu R. Effects of atrial fibrillation on coronary artery bypass graft flow. Eur J Cardiothorac Surg. 2003; 23(2): 175-178. doi:10.1016/s1010-7940(02)00730-3.

9. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 87-165. doi:10.1093/eurheartj/ehy394.

10. Chernyavskii AM, Rakhmonov SS, Pak IA, Kareva YuE. The results of treatment of atrial fibrillation with method of epicardial radiofrequency ablation of anatomic zones ganglionic plexi of the left atrium during CABG // Patologiya krovoobrashcheniya i kardiokhirurgiya. 2013; 17(2): 57-61. (In Russ.)

11. Li H, Lin X, Ma X, et al. Biatrial versus Isolated Left Atrial Ablation in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Biomed Res Int. 2018; 2018: 3651212. doi:10.1155/2018/3651212.

12. Attaran S, Saleh HZ, Shaw M, Ward A, Pullan M, Fabri BM. Does the outcome improve after radiofrequency ablation for atrial fibrillation in patients undergoing cardiac surgery? A propensity-matched comparison. Eur J Cardiothorac Surg. 2012; 41(4): 806-811. doi:10.1093/ejcts/ezr107.

13. Quader MA, McCarthy PM, Gillinov AM, et al. Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann Thorac Surg. 2004; 77(5): 1514-1524. doi:10.1016/j.athoracsur.2003.09.069.

14. Ad N, Cheng DC, Martin J, et al. Surgical Ablation for Atrial Fibrillation in Cardiac Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2009. Innovations (Phila). 2010; 5(2): 74-83. doi:10.1097/IMI.0b013e3181d72939.

15. Ad N, Suri RM, Gammie JS, Sheng S, O’Brien SM, Henry L. Surgical ablation of atrial fibrillation trends and outcomes in North America. J Thorac Cardiovasc Surg. 2012; 144(5): 1051-1060. doi:10.1016/j.jtcvs.2012.07.065.

16. Saxena A, Dinh D, Dimitriou J, et al. Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg. 2013; 16(4): 488-494. doi:10.1093/icvts/ivs538.

17. Weimar T, Bailey MS, Watanabe Y, et al. The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J Interv Card Electrophysiol. 2011; 31(1): 47-54. doi:10.1007/s10840-011-9547-3.

18. Worku B, Pak SW, Cheema F, et al. Incidence and predictors of pacemaker placement after surgical ablation for atrial fibrillation. Ann Thorac Surg. 2011; 92(6): 2085-2089. doi:10.1016/j.athoracsur.2011.07.058.

19. Damiano RJ Jr, Lawrance CP, Saint LL, et al. Detection of Atrial Fibrillation After Surgical Ablation: Conventional Versus Continuous Monitoring. Ann Thorac Surg. 2016; 101(1): 42-48. doi:10.1016/j.athoracsur.2015.07.039.

20. Al-Atassi T, Kimmaliardjuk DM, Dagenais C, Bourke M, Lam BK, Rubens FD. Should We Ablate Atrial Fibrillation During Coronary Artery Bypass Grafting and Aortic Valve Replacement? Ann Thorac Surg. 2017; 104(2): 515-522. doi:10.1016/j.athoracsur.2016.11.081.

21. Ad N, Henry L, Hunt S, Holmes SD. Impact of clinical presentation and surgeon experience on the decision to perform surgical ablation. Ann Thorac Surg. 2013; 96(3): 763-769. doi:10.1016/j.athoracsur.2013.03.066.

22. Kolbin AS, Mosikyan AA, Tatarskii BA. Socioeconomic burden of atrial fibrillations in russia: seven-year trends (2010-2017). Vestnik aritmologii. 2018; 92: 42-48. (In Russ.)

For citation

Borzov E.A. , Silaev A.A., Vasyagin E.V., Kolomeichenko N.A., Sukhotin V.N., Zorin E.V. Should we change the paradigm in the approach to the treatment of AF during CABG? Single center experience based on a randomized trial. Bulletin of Pirogov National Medical & Surgical Center. 2023;18(1):20-27. (In Russ.)